LNSR
LENSAR, Inc.
Key Financials
Operating Income
$-24578000
↓ 130.5%
Revenue
$58.4M
↑ 9.2%
Net Income
$-34280000
↓ 9.2%
EPS (Diluted)
$-2.87
↓ 5.1%
Total Assets
$71.4M
↑ 7.7%
Shareholders' Equity
$-26019000.00
↓ 635.2%
Total Liabilities
$83.7M
↑ 75.6%
Cash & Equivalents
$13.0M
↓ 20.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/15/2026 | View on SEC |
| 10-K | 3/31/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
| 4 | 3/19/2026 | View on SEC |
| 8-K | 3/17/2026 | View on SEC |
| 8-K/A | 3/13/2026 | View on SEC |
| 8-K | 3/12/2026 | View on SEC |
| 8-K | 2/25/2026 | View on SEC |
| 4 | 2/20/2026 | View on SEC |
| 4 | 2/20/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LNSR |
| Company Name | LENSAR, Inc. |
| CIK | 1320350 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 888-536-7271 |